Mining for regulatory programs in the cancer transcriptome

被引:135
作者
Rhodes, DR
Kalyana-Sundaram, S
Mahavisno, V
Barrette, TR
Ghosh, D
Chinnaiyan, AM [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Bioinformat Program, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/ng1578
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
DNA microarrays have been widely applied to cancer transcriptome analysis. The Oncomine database contains a large collection of such data, as well as hundreds of derived gene-expression signatures. We studied the regulatory mechanisms responsible for gene deregulation in these cancer signatures by searching for the coordinate regulation of genes with common transcription factor binding sites. We found that genes with binding sites for the archetypal cancer transcription factor, E2F, were disproportionately overexpressed in a wide variety of cancers, whereas genes with binding sites for other transcription factors, such as Myc-Max, c-Rel and ATF, were disproportionately overexpressed in specific cancer types. These results suggest that alterations in pathways activating these transcription factors may be responsible for the observed gene deregulation and cancer pathogenesis.
引用
收藏
页码:579 / 583
页数:5
相关论文
共 36 条
[1]   Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins [J].
Black, BL ;
Olson, EN .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1998, 14 :167-196
[2]   EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer [J].
Adrian P. Bracken ;
Diego Pasini ;
Maria Capra ;
Elena Prosperini ;
Elena Colli ;
Kristian Helin .
The EMBO Journal, 2003, 22 (20) :5323-5335
[3]   NF-κB family of transcription factors:: Central regulators of innate and adaptive immune functions [J].
Caamaño, J ;
Hunter, CA .
CLINICAL MICROBIOLOGY REVIEWS, 2002, 15 (03) :414-+
[4]   Role of histone H3 lysine 27 methylation in polycomb-group silencing [J].
Cao, R ;
Wang, LJ ;
Wang, HB ;
Xia, L ;
Erdjument-Bromage, H ;
Tempst, P ;
Jones, RS ;
Zhang, Y .
SCIENCE, 2002, 298 (5595) :1039-1043
[5]   Cdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycle-regulatory genes and cell cycle G1/S and G2/M transitions [J].
Chae, HD ;
Yun, J ;
Bang, YJ ;
Shin, DY .
ONCOGENE, 2004, 23 (23) :4084-4088
[6]  
DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215
[7]   Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells [J].
Elkon, R ;
Linhart, C ;
Sharan, R ;
Shamir, R ;
Shiloh, Y .
GENOME RESEARCH, 2003, 13 (05) :773-780
[8]   The c-Rel transcription factor and B-cell proliferation: a deal with the devil [J].
Gilmore, TD ;
Kalaitzidis, D ;
Liang, MC ;
Starczynowski, DT .
ONCOGENE, 2004, 23 (13) :2275-2286
[9]   Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas [J].
Houldsworth, J ;
Olshen, AB ;
Cattoretti, G ;
Donnelly, GB ;
Teruya-Feldstein, J ;
Qin, J ;
Palanisamy, N ;
Shen, YJ ;
Dyomina, K ;
Petlakh, M ;
Pan, Q ;
Zelentz, AD ;
Dalla-Favera, R ;
Chaganti, RSK .
BLOOD, 2004, 103 (05) :1862-1868
[10]  
Jean D, 2001, CRIT REV IMMUNOL, V21, P275